Psyence Biomedical (NASDAQ:PBM – Get Free Report) and Actuate Therapeutics (NASDAQ:ACTU – Get Free Report) are both small-cap healthcare companies, but which is the better investment? Get Psyence Biomedical alerts:Earnings & ValuationThis table compares Psyence Biomedical and Actuate Therapeutics”s top-line revenue, earnings per share (EPS) and valuation. Analyst RatingsThis is a summary of current ratings and recommmendations for Psyence Biomedical and Actuate Therapeutics, as reported by MarketBeat. Given Actuate Therapeutics’ stronger consensus rating and higher probable upside, analysts plainly believe Actuate Therapeutics is more favorable than Psyence Biomedical. Net Margins Return on Equity Return on Assets Psyence Biomedical N/A N/A N/A Actuate Therapeutics N/A -430.93% -180.86%SummaryPsyence Biomedical beats Actuate Therapeutics on 7 of the 11 factors compared between the two stocks.